News

The new distribution center will be engaged in distributing pharmaceutical products as well as CII-CV controlled substances and temperature controlled products to all 50 states and Puerto Rico.

Ellis will expand ImpactRx through its next phase of growth including the expansion of its Consulting Analytics business, which is fueled by the company’s proprietary ImpactData. From 2002

The EC approval has been granted for linagliptin in combination with metformin and metformin plus sulfonylurea. The product will be marketed under Trajenta trade name in Europe. The

D-Sorb, avalaibale in small easy-to-swallow softgels, provides 2000 IUs of Vitamin D3. The new Vitamin D supplement features SourceOne Global Partners’ VESIsorb lipid-based delivery system, which provides for

Earlier, Shire‘s Firazyr has been granted orphan drug status in the EU and US as a treatment for acute HAE. Firazyr is supplied in a pre-filled syringe that

The drug is designed to treat active rheumatoid arthritis and comes under a category of disease modifying anti-rheumatic drugs (DMARDS). The clinical studies demonstrate that Iremod can relieve

Baxa develops pharmacy technology including ExactaMix compounder, devices which automate multi-ingredient nutritional solution compounding and the DoseEdge Pharmacy Workflow Manager, an integrated system for managing IV and oral

The study is a dose-escalation, open-label, multiple-dose trial to evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.

Revlimid is indicated as a treatment for multiple myeloma and anemia due to myelodysplastic syndrome linked with a deletion in the long arm of the fifth chromosome. In